DuPont Capital Management Corporation »

Tevogen Bio Holdings shares owned by DuPont Capital Management Corporation

Quarter-by-quarter ownership of Tevogen Bio Holdings (TVGNW) shares owned by DuPont Capital Management Corporation from 13F filings

Historical chart of DuPont Capital Management Corporation investment in Tevogen Bio Holdings

Tip: Access up to 7 years of quarterly data

All positions including Tevogen Bio Holdings held by DuPont Capital Management Corporation consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Tevogen Bio Holdings by DuPont Capital Management Corporation

Quarter filed Position value Share count Share price at filing
2024-06-30 $251 13k 0.02
2024-03-31 $875 13k 0.07

More positions owned by DuPont Capital Management Corporation

Corteva Common Stock Usd.01 (CTVA)
Microsoft Corp Common Stock Usd.00000625 (MSFT)
Nvidia Corp Common Stock Usd.001 (NVDA)
Apple Common Stock Usd.00001 (AAPL)
Alphabet Inc Cl C Common Stock Usd.001 (GOOG)
Amazon.com Common Stock Usd.01 (AMZN)
Vanguard Ftse Emerging Markets Vanguard Ftse Emerging Marke (VWO)
Meta Platforms Inc Class A Common Stock Usd.000006 (META)
Ishares Msci Emerging Markets Ishares Msci Emerging Market (EEM)
Eli Lilly Common Stock (LLY)
Mastercard Inc A Common Stock Usd.0001 (MA)
Jpmorgan Chase Common Stock Usd1.0 (JPM)
Taiwan Semiconductor Sp Adr (TSM)
Walmart Common Stock Usd.1 (WMT)
Unitedhealth Group Common Stock Usd.01 (UNH)

View all positions for DuPont Capital Management Corporation

Top funds holding Tevogen Bio Holdings

Parallax Volatility Advisers
Highbridge Capital Management
FourWorld Capital Management
Corbin Capital Partners
Calamos Advisors
Polar Securities
MMCAP International Inc. SPC
Periscope Capital
HGC Investment Management
Atalaya Capital Management
Shaolin Capital Management
Cantor Fitzgerald, L. P.
Davidson Kempner Capital Management
Aristeia Capital
Wolverine Asset Management

View all funds holding Tevogen Bio Holdings